Related Content
- InsightApril 24, 2024
Healthcare M&A and Financing Trends and Predictions for 2024
- InsightApril 24, 2024
European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy
- AlertApril 15, 2024
Delaware Supreme Court Holds That Boards Must Satisfy the MFW Framework in Controller Transactions to Obtain Business Judgment Deference
- NewslettersApril 4, 2024
SEC Adopts Reforms Relating to Investment Advisers Operating Exclusively Through the Internet
- Alert28 March 2024
At the Intersection of ‘S’ and ‘G’ of ESG: London Leading the Way on Board Diversity — An Update on Latest FTSE Women Leaders Review and Parker Review Reports
- NewslettersMarch 28, 2024
Agencies Extend Applicability Date of Certain Provisions of their CRA Final Rule
- NewslettersMarch 21, 2024
FinCEN Publishes an Administrative Ruling Regarding Customer Identification Program and Customer Due Diligence Requirements for Designated Beneficiaries of Individual Retirement Accounts
- NewslettersMarch 14, 2024
Federal Reserve Announces Final Rule Updating Risk Management Requirements for Certain Systemically Important Financial Market Utilities
- Speaking EngagementsMay 14, 2024
What Tech Companies Need to Know: State of Tech M&A Panel
- Press ReleaseApril 11, 2024
Digital Markets Guide: US Skepticism of Tech Transactions Sparks a Step-Up in Merger Enforcement (GCR)
- Press ReleaseApril 10, 2024
Alpine Immune Sciences To Be Acquired by Vertex Pharmaceuticals For $4.9 Billion
- Press ReleaseApril 10, 2024
Auradine Raises $80 Million in Series B Financing and Achieves $80 Million in Bookings
- In the PressApril 9, 2024
Deal Watch: M&A (Law.com)
- In the PressApril 4, 2024
US Law Firms Ride Rising M&A Wave in Q1 (Reuters)
- In the PressApril 4, 2024
Q1 PE League Tables: Making it Private (The Deal)
- Press ReleaseApril 3, 2024
AlmataBio Acquired by Avalo Therapeutics For $22.5 Million